Literature DB >> 8006866

Some aspects of cancer medicine.

J S Malpas1.   

Abstract

The role of molecular oncology in understanding the nature of the cancer cell, and as an aid to diagnosis and even therapy, is discussed and illustrated with examples from commonly occurring malignancies. The appreciation of the importance of cell biology in explaining why cells become resistant to anticancer drugs has developed rapidly, and examples are given. Cell biology and molecular biology contribute to cancer prevention, which is becoming a practical possibility. Haemopoietic growth factors make it possible to give more intensive chemotherapy treatments and to improve the survival rate in patients with chemoresponsive disease. Intensification, however, has to be balanced against the risk of both short-term and, more seriously, long-term toxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006866      PMCID: PMC5400893     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  17 in total

Review 1.  The human hematopoietic colony-stimulating factors.

Authors:  S C Clark; R Kamen
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

2.  Tamoxifen and contralateral breast cancer.

Authors:  J Cuzick; M Baum
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

3.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

4.  13-cis-retinoic acid in the treatment of oral leukoplakia.

Authors:  W K Hong; J Endicott; L M Itri; W Doos; J G Batsakis; R Bell; S Fofonoff; R Byers; E N Atkinson; C Vaughan
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

5.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

6.  Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.

Authors:  K H Kraemer; J J DiGiovanna; A N Moshell; R E Tarone; G L Peck
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

7.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

Review 8.  Retinoids in cancer treatment.

Authors:  M S Tallman; P H Wiernik
Journal:  J Clin Pharmacol       Date:  1992-10       Impact factor: 3.126

9.  Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.

Authors:  B R O'Driscoll; P S Hasleton; P M Taylor; L W Poulter; H R Gattameneni; A A Woodcock
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

10.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.

Authors:  S E Lipshultz; S D Colan; R D Gelber; A R Perez-Atayde; S E Sallan; S P Sanders
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.